Iconovo (ST:ICO) — Market Cap & Net Worth
Market Cap & Net Worth: Iconovo (ICO)
Iconovo (ST:ICO) has a market capitalization of $12.26 Million (Skr113.96 Million) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #26622 globally and #561 in its home market, demonstrating a -13.19% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Iconovo's stock price Skr1.19 by its total outstanding shares 96171916 (96.17 Million). Also see ICO total asset value for a full breakdown of the balance sheet.
Iconovo Market Cap History: 2018 to 2026
Iconovo's market capitalization history from 2018 to 2026. Data shows change from $362.24 Million to $12.26 Million (-33.21% CAGR). Also see how efficiently does Iconovo generate cash for how efficiently the company converts equity into cash flow.
Index Memberships
Iconovo is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.23 Billion | 0.08% | #148 of 281 |
Weight: Iconovo's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Iconovo Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Iconovo's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Iconovo for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
10.68x
Iconovo's market cap is 10.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $362.24 Million | $11.91 Million | -$4.29 Million | 30.42x | N/A |
| 2019 | $807.27 Million | $11.74 Million | -$11.01 Million | 68.78x | N/A |
| 2020 | $521.62 Million | $17.79 Million | -$17.13 Million | 29.32x | N/A |
| 2021 | $796.92 Million | $15.41 Million | -$26.16 Million | 51.72x | N/A |
| 2022 | $507.13 Million | $17.12 Million | -$50.31 Million | 29.63x | N/A |
| 2023 | $119.54 Million | $7.08 Million | -$45.89 Million | 16.89x | N/A |
| 2024 | $42.85 Million | $2.93 Million | -$41.14 Million | 14.60x | N/A |
| 2025 | $11.80 Million | $1.10 Million | -$43.36 Million | 10.68x | N/A |
Competitor Companies of ICO by Market Capitalization
Companies near Iconovo in the global market cap rankings as of September 19, 2026. Review ICO tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Iconovo by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Iconovo Historical Marketcap From 2018 to 2026
Between 2018 and today, Iconovo's market cap moved from $362.24 Million to $ 12.26 Million, with a yearly change of -33.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr12.26 Million | +3.95% |
| 2025 | Skr11.80 Million | -72.46% |
| 2024 | Skr42.85 Million | -64.16% |
| 2023 | Skr119.54 Million | -76.43% |
| 2022 | Skr507.13 Million | -36.36% |
| 2021 | Skr796.92 Million | +52.78% |
| 2020 | Skr521.62 Million | -35.38% |
| 2019 | Skr807.27 Million | +122.86% |
| 2018 | Skr362.24 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Iconovo was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.26 Million USD |
| MoneyControl | $12.26 Million USD |
| MarketWatch | $12.26 Million USD |
| marketcap.company | $12.26 Million USD |
| Reuters | $12.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Iconovo
Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more